September 17, 2024

Now Enrolling: PrE1702 Real-World Data Study for Patients with EGFR-Mutated Non-Small Cell Lung Cancer Not Enrolled in Clinical Trials

This innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial